Dianna L. Ng

Dianna L. Ng

Auto-generated profile, based on publicly available information

Dianna L. Ng

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in The American Journal of Pathology
Verified
Journal Article
Closed access
DNDianna L. Ng
Dianna L. Ng
FHFarida Al Hosani
Farida Al Hosani
MKM. Kelly Keating
M. Kelly Keating
SGSusan I. Gerber
Susan I. Gerber
TJTara L. Jones
Tara L. Jones
SZSherif R. Zaki
Sherif R. Zaki

11 December 2014 in The Journal of Pathology
Verified
Journal Article
Closed access
PDF file
RMRoosecelis Brasil Martines
Roosecelis Brasil Martines
DNDianna L. Ng
Dianna L. Ng
PGPatricia W. Greer
Patricia W. Greer
PRPierre E Rollin
Pierre E Rollin
SZSherif R. Zaki
Sherif R. Zaki

5 February 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
DNDianna L. Ng
Dianna L. Ng
AGAndrea C. Granados
Andrea C. Granados
YSYale A. Santos
Yale A. Santos
VSVenice Servellita
Venice Servellita
GGGregory M. Goldgof
Gregory M. Goldgof
CCCharles Y. Chiu
Charles Y. Chiu
SARS-CoV-2 infection elicits a distinct host response in nasal swabs and blood that can be used to diagnose COVID-19.

1 October 2020 in Cell Reports Medicine
Verified
Journal Article
Open access
CZColin R. Zamecnik
Colin R. Zamecnik
JRJayant V. Rajan
Jayant V. Rajan
KYKevin A. Yamauchi
Kevin A. Yamauchi
SMSabrina A. Mann
Sabrina A. Mann
RLRita P. Loudermilk
Rita P. Loudermilk
MWMichael Wilson
Michael Wilson
Comprehensive understanding of the serological response to SARS-CoV-2 infection is important for both pathophysiologic insight and diagnostic development. Here, we generate a pan-human coronavirus programmable phage display assay to perform proteome-wide profiling of coronavirus antigens enriched by 98 COVID-19 patient sera. Next, we use ReScan, a method to efficiently sequester phage expressing the most immunogenic peptides and print them onto paper-based microarrays using acoustic liquid handling, which isolates and identifies nine candidate antigens, eight of which are derived from the two proteins used for SARS-CoV-2 serologic assays: spike and nucleocapsid proteins. After deployment in a high-throughput assay amenable to clinical lab settings, these antigens show improved specificity over a whole protein panel. This proof-of-concept study demonstrates that ReScan will have broad applicability for other emerging infectious diseases or autoimmune diseases that lack a valid biomarker, enabling a seamless pipeline from antigen discovery to diagnostic using one recombinant protein source.

1 May 2016 in The American Journal of Pathology
Verified
Journal Article
Closed access
AMAtis Muehlenbachs
Atis Muehlenbachs
BBBrigid C. Bollweg
Brigid C. Bollweg
TSThadeus J. Schulz
Thadeus J. Schulz
JFJoseph D. Forrester
Joseph D. Forrester
MCMarlene DeLeon Carnes
Marlene DeLeon Carnes
SZSherif R. Zaki
Sherif R. Zaki

20 February 2015
Verified
Journal Article
Closed access
SVSnigdha Vallabhaneni
Snigdha Vallabhaneni
TWTiffany A. Walker
Tiffany A. Walker
SLShawn R. Lockhart
Shawn R. Lockhart
DNDianna Ng
Dianna Ng
TCTom Chiller
Tom Chiller
RSRachel M. Smith
Rachel M. Smith